Topical carvedilol delivery prevents UV-induced skin cancer with negligible systemic absorption-Reference-Cited by-同舟云学术

Topical carvedilol delivery prevents UV-induced skin cancer with negligible systemic absorption

Published:2022-01 Issue: Volume:611 Page:121302
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Abdullah Shamim Md,Yeung Steven,Shahid Ayaz,Chen Mengbing,Wang Jeffrey,Desai Preshita,Parsa Cyrus,Orlando Robert,Meyskens Jr Frank L.,Kelly Kristen M.,Andresen Bradley T.,Huang Ying

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference34 articles.

1. Tamoxifen-loaded novel liposomal formulations: evaluation of anticancer activity on DMBA-TPA induced mouse skin carcinogenesis;Bhatia;J. Drug Target,2012

2. Prevention of skin carcinogenesis by the beta-blocker carvedilol;Chang;Cancer Prev. Res (Phila),2015

3. Isoproterenol-Induced Heart Failure Mouse Model Using Osmotic Pump Implantation;Chang;Methods Mol. Biol.,2018

4. The beta-Blocker Carvedilol Prevented Ultraviolet-Mediated Damage of Murine Epidermal Cells and 3D Human Reconstructed Skin;Chen;Int. J. Mol. Sci.,2020

5. Topical Delivery of Carvedilol Loaded Nano-Transfersomes for Skin Cancer Chemoprevention;Chen;Pharmaceutics,2020

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An overview of phospholipid enriched-edge activator-based vesicle nanocarriers: New paradigms to treat skin cancer;Journal of Drug Targeting;2024-09-09

2. Long-term ultraviolet B irradiation at 297 nm with light-emitting diode improves bone health via vitamin D regulation;Biomedical Optics Express;2024-06-04

3. Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence;European Heart Journal;2024-03-05

4. Oral intake of bucillamine, carvedilol, metformin, or phenformin does not protect against UVR-induced squamous cell carcinomas in hairless mice;Photochemical & Photobiological Sciences;2024-02-09

5. Drug Repurposing in Cancer Therapy;Drug Repurposing;2024